Research programme: camptothecin pro-drugs - Dekk-Tec

Drug Profile

Research programme: camptothecin pro-drugs - Dekk-Tec

Alternative Names: 7-butyl-10-amino-camptothecin pro-drug; BACPT; BACPTDP

Latest Information Update: 03 Dec 2010

Price : $50

At a glance

  • Originator Dekk-Tec
  • Class Camptothecins
  • Mechanism of Action DNA topoisomerase I inhibitors; Hypoxia-inducible factor 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 19 Nov 2009 Preclinical trials in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top